Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Lavender Sky Health vs Navio MD

Lavender Sky Health
Graded #152

Lower grade

vs+1.0999999999999943
Navio MD
Graded #126

Higher grade

The verdict

Navio MD takes it — 69.5/100 to 68.4/100, but only just.

Navio MD grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. NavioMD offers compounded tirzepatide ($247/mo) plus brand-name Ozempic ($1,199/mo) and Mounjaro ($1,249/mo). Lavender Sky Health is close behind and may still be the better fit — see the factor split below.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueLavender Sky Health +19
75
56
Dose & formulationNavio MD +13
64
77
Clinical oversightNavio MD +13
74
87
Labs & monitoringNavio MD +1
53
54
FulfillmentNavio MD +4
81
85
Contract termsEven
55
55
Lavender Sky Health · left barNavio MD · right bar

The numbers

MetricLavender Sky HealthNavio MD
WeighScore68.4/10069.5/100
GradeCC
Scorecard rank#152#126
Semaglutide$139/mo (starting dose, month to month, Southend Pharmacy, compounded)$345/mo (starting dose, brand-name)
Tirzepatide$149/mo (starting dose, month to month, ReviveRx, compounded)$189/mo (starting dose, compounded)
CoverageAll 50 states48 states
Brand-name accessCompounded onlyYes
Oral / sublingualInjection onlyInjection only
Lavender Sky Health

Graded #152 · C

Strengths

  • The treatment-plan pricing page publishes every pharmacy's full ladder rather than one headline figure, so the cheaper prepaid tiers are visible alongside the monthly ones
  • A genuine month-to-month starter plan exists with no prepay, and the cheapest of them is what is filed above — Southend for semaglutide, ReviveRx for tirzepatide
  • Compounded plans include the price of the medication, and shipping and supplies are stated as included
  • Both semaglutide and tirzepatide are offered, across roughly ten named compounding pharmacies

Where it loses points

  • This is a marketplace, not one price: every figure belongs to a named pharmacy on a named plan, and the pharmacy and plan have to travel with the number for it to mean anything
  • Most of the ladder is prepaid — Tier plans need 8-10 weeks up front and Extended plans 3-4 months — and only a handful of the pharmacies publish a month-to-month starter plan at all
  • Brand-name plans add a separate $25 monthly treatment-plan fee and explicitly do not include the price of the medication; only the compounded plans include it
  • No price appears on the homepage, and the pricing page is the only place the ladders are published
  • Compounded semaglutide and tirzepatide are not FDA-approved finished products
Navio MD

Graded #126 · C

Strengths

  • LegitScript verified with board-certified providers and US-licensed pharmacies
  • Both compounded and brand-name options
  • 48-state coverage
  • Hours 9am–10pm EST Mon–Sun
  • Transparent tiered pricing: you only pay for your current dose

Where it loses points

  • Not available in Alabama and Mississippi
  • Compounded option is tirzepatide only — no compounded semaglutide listed
  • Also offers women's HRT (broader platform)
  • Pricing is tiered by dose ('as low as'); the entry prices climb as your dose increases

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard